Maxime Fouyssac

Maxime Fouyssac

Auto-generated profile, based on publicly available information

Maxime Fouyssac

Department of Psychology University of Cambridge Cambridge UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Biological Psychiatry
Verified
Journal Article
Open access
ABAude Belin-Rauscent
Aude Belin-Rauscent
MFMaxime Fouyssac
Maxime Fouyssac
ABAntonello Bonci
Antonello Bonci
DBDavid Belin
David Belin
Drug addiction is a complex neuropsychiatric disorder that affects a subset of the individuals who take drugs. It is characterized by maladaptive drug-seeking habits that are maintained despite adverse consequences and intense drug craving. The pathophysiology and etiology of addiction is only partially understood despite extensive research because of the gap between current preclinical models of addiction and the clinical criteria of the disorder. This review presents a brief overview, based on selected methodologies, of how behavioral models have evolved over the last 50 years to the development of recent preclinical models of addiction that more closely mimic diagnostic criteria of addiction. It is hoped that these new models will increase our understanding of the complex neurobiological mechanisms whereby some individuals switch from controlled drug use to compulsive drug-seeking habits and relapse to these maladaptive habits. Additionally, by paving the way to bridge the gap that exists between biobehavioral research on addiction and the human situation, these models may provide new perspectives for the development of novel and effective therapeutic strategies for drug addiction.

1 February 2021 in Addiction Biology
Verified
Journal Article
Open access
PDF file
LMLucia Marti‐Prats
Lucia Marti‐Prats
ABAude Belin‐Rauscent
Aude Belin‐Rauscent
MFMaxime Fouyssac
Maxime Fouyssac
MPMickaël Puaud
Mickaël Puaud
PCPaul J Cocker
Paul J Cocker
DBDavid Belin
David Belin
While most individuals with access to alcohol drink it recreationally, some vulnerable individuals eventually lose control over their intake and progressively develop compulsive alcohol drinking and decreased interest in alternative sources of reinforcement, two key features of addiction. The neural and molecular mechanisms underlying this vulnerability to switch from controlled to compulsive alcohol intake have not been fully elucidated. It has been shown that rats having reduced levels of expression of the gamma‐aminobutyric acid (GABA) transporter, GAT‐3, in the amygdala tend to persist in seeking and drinking alcohol even when adulterated with quinine, suggesting that pharmacological interventions aimed at restoring GABA homeostasis in these individuals may provide a targeted treatment to limit compulsive alcohol drinking. Here, we tested the hypothesis that the GABAB receptor agonist baclofen, which decreases GABA release, specifically reduces compulsive alcohol drinking in vulnerable individuals. In a large cohort of Sprague–Dawley rats allowed to drink alcohol under an intermittent two‐bottle choice procedure, a cluster of individuals was identified that persisted in drinking alcohol despite adulteration with quinine or when an alternative ingestive reinforcer, saccharin, was available. In these rats, which were characterized by decreased GAT‐3 mRNA levels in the central amygdala, acute baclofen administration (1.5 mg/kg, intraperitoneal) resulted in a decrease in compulsive drinking. These results indicate that low GAT‐3 mRNA levels in the central amygdala may represent an endophenotype of vulnerability to develop a compulsive drinking of alcohol that is shown here to be mitigated by baclofen.

9 April 2019 in European Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
MFMaxime Fouyssac
Maxime Fouyssac
DBDavid Belin
David Belin
The transition from recreational drug use to compulsive drug‐seeking habits, the hallmark of addiction, has been shown to depend on a shift in the locus of control over behaviour from the ventral to the dorsolateral striatum. This process has hitherto been considered to depend on the aberrant engagement of dopamine‐dependent plasticity processes within neuronal networks. However, exposure to drugs of abuse also triggers cellular and molecular adaptations in astrocytes within the striatum which could potentially contribute to the intrastriatal transitions observed during the development of drug addiction. Pharmacological interventions aiming to restore the astrocytic mechanisms responsible for maintaining homeostatic glutamate concentrations in the nucleus accumbens, that are altered by chronic exposure to addictive drugs, abolish the propensity to relapse in both preclinical and, to a lesser extent, clinical studies. Exposure to drugs of abuse also alters the function of astrocytes in the dorsolateral striatum, wherein dopaminergic mechanisms control drug‐seeking habits, associated compulsivity and relapse. This suggests that drug‐induced alterations in the glutamatergic homeostasis maintained by astrocytes throughout the entire striatum may interact with dopaminergic mechanisms to promote aberrant plasticity processes that contribute to the maintenance of maladaptive drug‐seeking habits. Capitalising on growing evidence that astrocytes play a fundamental regulatory role in glutamate and dopamine transmission in the striatum, we present an innovative model of a quadripartite synaptic microenvironment within which astrocytes channel functional interactions between the dopaminergic and glutamatergic systems that may represent the primary striatal functional unit that undergoes drug‐induced adaptations eventually leading to addiction.

1 June 2022 in Biological Psychiatry
Verified
Journal Article
Closed access
MFMaxime Fouyssac
Maxime Fouyssac
YPYolanda Peña-Oliver
Yolanda Peña-Oliver
MPMickaёl Puaud
Mickaёl Puaud
NLNicole T.Y. Lim
Nicole T.Y. Lim
CGChiara Giuliano
Chiara Giuliano
DBDavid Belin
David Belin

28 September 2023 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
LMLucia Marti-Prats
Lucia Marti-Prats
CGChiara Giuliano
Chiara Giuliano
ADAna Domi
Ana Domi
MPMickaël Puaud
Mickaël Puaud
YPYolanda Peña-Oliver
Yolanda Peña-Oliver
DBDavid Belin
David Belin
Humans greatly differ in how they cope with stress, a natural behavior learnt through negative reinforcement. Some individuals engage in displacement activities, others in exercise or comfort eating, and others still in alcohol use. Across species, adjunctive behaviors, such as polydipsic drinking, are used as a form of displacement activity that reduces stress. Some individuals, in particular those that use alcohol to self-medicate, tend to lose control over such coping behaviors, which become excessive and compulsive. However, the psychological and neural mechanisms underlying this individual vulnerability have not been elucidated. Here we tested the hypothesis that the development of compulsive adjunctive behaviors stems from the functional engagement of the dorsolateral striatum (DLS) dopamine-dependent habit system after a prolonged history of adjunctive responding. We measured in longitudinal studies in male Sprague Dawley rats the sensitivity of early established vs compulsive polydipsic water or alcohol drinking to a bilateral infusion into the anterior DLS (aDLS) of the dopamine receptor antagonist α-flupentixol. While most rats acquired a polydipsic drinking response with water, others only did so with alcohol. Whether drinking water or alcohol, the acquisition of this coping response was insensitive to aDLS dopamine receptor blockade. In contrast, after prolonged experience, adjunctive drinking became dependent on aDLS dopamine at a time when it was compulsive in vulnerable individuals. These data suggest that habits may develop out of negative reinforcement and that the engagement of their underlying striatal system is necessary for the manifestation of compulsive adjunctive behaviors.

13 March 2025 in European Journal of Neuroscience
Verified
Journal Article
Open access
MFMaxime Fouyssac
Maxime Fouyssac
THTristan Hynes
Tristan Hynes
ABAude Belin‐Rauscent
Aude Belin‐Rauscent
DJDhaval D. Joshi
Dhaval D. Joshi
DBDavid Belin
David Belin
The development of compulsive cue‐controlled‐incentive drug‐seeking habits is a hallmark of substance use disorder that is predicated on an intrastriatal shift in the locus of control over behaviour from a nucleus accumbens (Nac) core–dorsomedial striatum network to a Nac core–anterior dorsolateral striatum (aDLS) network. This shift is paralleled by drug‐induced (including cocaine) dopamine transporter (DAT) alterations originating in the ventral striatum that spread eventually to encompass the aDLS. Having recently shown that heroin self‐administration results in a pan‐striatal reduction in astrocytic DAT that precedes the development of aDLS dopamine‐dependent incentive heroin‐seeking habits, we tested the hypothesis that similar adaptations occur following cocaine exposure. We compared DAT protein levels in whole tissue homogenates, and in astrocytes cultured from ventral and dorsal striatal territories of drug‐naïve male Sprague–Dawley rats to those of rats with a history of cocaine taking or an aDLS dopamine‐dependent incentive cocaine‐seeking habit. Cocaine exposure resulted in a decrease in whole tissue and astrocytic DAT across all territories of the striatum. We further demonstrated that compulsive (i.e., punishment‐resistant) incentive cocaine‐seeking habits were associated with a reduction in DAT mRNA levels in the Nac shell, but not the Nac core‐aDLS incentive habit system. Together with the recent evidence of heroin‐induced downregulation of striatal astrocytic DAT, these findings suggest that alterations in astrocytic DAT may represent a common mechanism underlying the development of compulsive incentive drug‐seeking habits across drug classes.